PH-D Feminine Health Systems is a Tennessee-based biopharma company that works in pharmaceuticals focused on products for women's health. Their filings show they engaged lobbyists at the law firm Squire Patton Boggs, but reported no federal lobbying expenditures across five filings. Based on available disclosures, they likely contact lawmakers about issues related to their pharmaceutical products or regulatory matters affecting feminine health, though specifics aren’t provided.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
This client has not yet disclosed issue activity in the available filings.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
No lobbyists are disclosed for this client yet.
The latest disclosures for this client.
SQUIRE PATTON BOGGS
Q3YSQUIRE PATTON BOGGS
Q2YSQUIRE PATTON BOGGS
Q1YThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
SQUIRE PATTON BOGGS
Q4YSQUIRE PATTON BOGGS
Q3YSQUIRE PATTON BOGGS
Q2YSQUIRE PATTON BOGGS
Q1Y